REPORT ID 20811

United States Flu Vaccine Market 2017

Publish Date
17-May
Pages
105
Format
Electronic (PDF)

In this report, the United States Flu Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Flu Vaccine in these regions, from 2012 to 2022 (forecast).

United States Flu Vaccine market competition by top manufacturers/players, with Flu Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi-pasteur
    Novartis
    GSK
    Abbott
    Pfizer
    CSL
    Hualan Bio
    Changchun Bio
    Alephbio
    Sinovac
    CS Vaccine
    Tianyuan Bio
    Tiantan Bio
    Siobp

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Whole Virus Vaccines
    Split Virus Vaccines
    Subunit Or Surface Antigen Vaccines
    Live Attenuated (Cold-Adapted) Virus Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Flu Vaccine for each application, including
    For Children (6 months to 3 years old)
    For Adult and Children over 3 years
 
			   
United States Flu Vaccine Market Report 2017
1 Flu Vaccine Overview
    1.1 Product Overview and Scope of Flu Vaccine
    1.2 Classification of Flu Vaccine by Product Category
        1.2.1 United States Flu Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Flu Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Whole Virus Vaccines
        1.2.4 Split Virus Vaccines
        1.2.5 Subunit Or Surface Antigen Vaccines
        1.2.6 Live Attenuated (Cold-Adapted) Virus Vaccines
    1.3 United States Flu Vaccine Market by Application/End Users
        1.3.1 United States Flu Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 For Children (6 months to 3 years old)
        1.3.3 For Adult and Children over 3 years
    1.4 United States Flu Vaccine Market by Region
        1.4.1 United States Flu Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Flu Vaccine Status and Prospect (2012-2022)
        1.4.3 Southwest Flu Vaccine Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Flu Vaccine Status and Prospect (2012-2022)
        1.4.5 New England Flu Vaccine Status and Prospect (2012-2022)
        1.4.6 The South Flu Vaccine Status and Prospect (2012-2022)
        1.4.7 The Midwest Flu Vaccine Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Flu Vaccine (2012-2022)
        1.5.1 United States Flu Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 United States Flu Vaccine Revenue and Growth Rate (2012-2022)

2 United States Flu Vaccine Market Competition by Players/Suppliers
    2.1 United States Flu Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Flu Vaccine Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Flu Vaccine Average Price by Players/Suppliers (2012-2017)
    2.4 United States Flu Vaccine Market Competitive Situation and Trends
        2.4.1 United States Flu Vaccine Market Concentration Rate
        2.4.2 United States Flu Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Flu Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Flu Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Flu Vaccine Sales and Market Share by Region (2012-2017)
    3.2 United States Flu Vaccine Revenue and Market Share by Region (2012-2017)
    3.3 United States Flu Vaccine Price by Region (2012-2017)

4 United States Flu Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Flu Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Flu Vaccine Revenue and Market Share by Type (2012-2017)
    4.3 United States Flu Vaccine Price by Type (2012-2017)
    4.4 United States Flu Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Flu Vaccine Sales (Volume) by Application (2012-2017)
    5.1 United States Flu Vaccine Sales and Market Share by Application (2012-2017)
    5.2 United States Flu Vaccine Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 United States Flu Vaccine Players/Suppliers Profiles and Sales Data
    6.1 Sanofi-pasteur
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Flu Vaccine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi-pasteur Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis
        6.2.2 Flu Vaccine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GSK
        6.3.2 Flu Vaccine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GSK Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Abbott
        6.4.2 Flu Vaccine Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abbott Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Pfizer
        6.5.2 Flu Vaccine Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Pfizer Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 CSL
        6.6.2 Flu Vaccine Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 CSL Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Hualan Bio
        6.7.2 Flu Vaccine Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Hualan Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Changchun Bio
        6.8.2 Flu Vaccine Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Changchun Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Alephbio
        6.9.2 Flu Vaccine Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Alephbio Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Sinovac
        6.10.2 Flu Vaccine Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Sinovac Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 CS Vaccine
    6.12 Tianyuan Bio
    6.13 Tiantan Bio
    6.14 Siobp

7 Flu Vaccine Manufacturing Cost Analysis
    7.1 Flu Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Flu Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Flu Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Flu Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Flu Vaccine Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Flu Vaccine Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Flu Vaccine Sales Volume Forecast by Type (2017-2022)
    11.3 United States Flu Vaccine Sales Volume Forecast by Application (2017-2022)
    11.4 United States Flu Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer